Announcements Trials
Browse Landscape

Status

Recruiting 12Completed 11Active not recruiting 10Withdrawn 4Unknown 4Terminated 2Suspended 1Not yet recruiting 1No longer available 1Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1

Interventions

elotuzumab 4Lenalidomide 3Dexamethasone 3Bortezomib 3Panobinostat 2ulocuplumab 1talquetamab 1selinexor 1pomalidomide 1plerixafor 1fludarabine phosphate 1carfilzomib 1Whole-Body Irradiation 1Tacrolimus 1Prednisone 1Mycophenolic Acid 1Melphalan 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Multiple Myeloma × selinexor × Clear all
NCT03850704 2019-02-22

Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma

Masonic Cancer Center, University of Minnesota

No longer available
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡